Home
|
Inbox
|
Search
|
Event
Preclinical Investigation of Safety, Pharmacokinetics and Neoantigenicity of a Liquid Formulation of the Alpha-1 Proteinase Inhibitor Prolastin-C® [Board No. P1392]
Location: Board no. P1392
Session Type: Thematic Poster Session
Sunday
May
20
11:15 AM
1:00 PM
Speaker(s)/Author(s)
|
Home
|
Inbox
|
Search
|